Compare ICE & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ICE | ELV |
|---|---|---|
| Founded | 2000 | 1944 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.5B | 85.7B |
| IPO Year | 2013 | 2001 |
| Metric | ICE | ELV |
|---|---|---|
| Price | $140.21 | $414.86 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 19 |
| Target Price | $194.78 | ★ $383.56 |
| AVG Volume (30 Days) | ★ 3.4M | 1.4M |
| Earning Date | 04-30-2026 | 04-22-2026 |
| Dividend Yield | 1.33% | ★ 1.83% |
| EPS Growth | ★ 20.71 | N/A |
| EPS | 2.48 | ★ 8.00 |
| Revenue | $5,834,000,000.00 | ★ $199,125,000,000.00 |
| Revenue This Year | $10.29 | N/A |
| Revenue Next Year | $4.76 | $3.07 |
| P/E Ratio | $57.10 | ★ $51.17 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $136.67 | $273.71 |
| 52 Week High | $189.35 | $411.80 |
| Indicator | ICE | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 29.45 | 68.74 |
| Support Level | N/A | $307.16 |
| Resistance Level | $161.54 | N/A |
| Average True Range (ATR) | 3.69 | 9.81 |
| MACD | -1.11 | -0.87 |
| Stochastic Oscillator | 15.83 | 92.56 |
Intercontinental Exchange is a vertically integrated operator of financial exchanges and provides ancillary data products. Though the company is probably best known for its ownership of the New York Stock Exchange, which it acquired in 2013, ICE operates a large derivatives exchange, too. The company's largest commodity futures product is the ICE Brent crude futures contract. In addition to the exchanges business, which is about 54% of net revenue, Intercontinental Exchange has used a series of acquisitions to create its mortgage technology business (22% of net revenue) and fixed-income and data-services segment (24% of net revenue).
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.